Podcast Summary
Podcast: Becker’s Healthcare Podcast
Episode: Scott Becker - Tempus AI: A Tempus and a Teapot
Date: August 27, 2025
Host: Scott Becker
Overview
In this episode, Scott Becker delves into the growing role and critical importance of Tempus AI, a predictive analytics and artificial intelligence company, within the contemporary healthcare system—especially in the realm of oncology. Becker discusses the pressures oncologists face, the evolution of Tempus AI, and the broader need for advanced clinical decision tools. He frames Tempus AI as a response to overwhelming clinical workloads and knowledge gaps exacerbated by the complexity of modern cancer care.
Key Discussion Points & Insights
1. Introduction to Tempus AI and Its Founder
- Tempus AI specializes in data analytics and AI-driven predictive analytics, aiding health systems, oncologists, and medical groups in making sense of oncology diagnoses and determining optimal steps forward.
- Founder: Eric Lefkowski, noted as a "brilliant, brilliant entrepreneur" from Glencoe, Illinois. The company has been around for about a decade.
(00:21)
2. The Growing Need for AI Solutions in Oncology
- Becker highlights an "intersection in time" making companies like Tempus AI widely relevant and vital.
- Oncologists are described as "overwhelmed" by the explosion of treatment options, care protocols, and the ever-expanding field of oncology knowledge.
- The immense workload means doctors "have limited bandwidth because they're exhausted."
(00:48) - The resulting strain is not a "knock on them," but shows the need for supportive, scalable technology.
(01:22) - "It's almost impossible" for individual oncologists to keep up, leading patients to seek care at major centers such as MD Anderson, Mayo Clinic, City of Hope, and Cleveland Clinic.
- These institutions are credited for having a "depth of talent," which becomes a reason for repeated patient referrals.
(01:33)
- These institutions are credited for having a "depth of talent," which becomes a reason for repeated patient referrals.
3. Tempus AI’s Value Proposition
- Companies like Tempus AI and Private Health Management are “so, so valuable and so important in different ways because of the space that they fill that our medical professionals, our physicians can’t fill because they’re often just overwhelmed or work in a silo.”
- Highlights the support AI provides outside traditional, overburdened systems. (01:52)
- Tempus AI is on an upward trajectory, described as being up 117-118% year to date, reflecting its increasing adoption and market confidence.
- Quote: “It’s up 117, 118% year to date.”
(02:18)
- Quote: “It’s up 117, 118% year to date.”
4. Personal Experience with Tempus AI
- Becker shares a personal anecdote: when his nephew was diagnosed with brain cancer, he discovered the health system was cross-checking all decisions with Tempus AI.
- Portrays Tempus as moving from an entrepreneurial experiment to “a real, real thing.”
(02:42) - Quote: “I was actually shocked to learn that the health system we were working with checked everything they did with Tempus AI that had been assigned to me, that had moved beyond just sort of this guy Eeroka Afkowski’s company to a real, real thing.”
(02:42)
- Portrays Tempus as moving from an entrepreneurial experiment to “a real, real thing.”
5. Oncology Workforce Pressures and the Future
- The ongoing shortage of healthcare professionals and the high rates of cancer emphasize the invaluable contribution of AI-driven tools.
- The episode concludes by reiterating that such tools are “so, so important because quite frankly, the doctors are overwhelmed.”
(03:20)- Quote: “It’s no question why these types of things, these types of AI, clinical helpful tools are so, so important because quite frankly, the doctors are overwhelmed.”
(03:20)
- Quote: “It’s no question why these types of things, these types of AI, clinical helpful tools are so, so important because quite frankly, the doctors are overwhelmed.”
Notable Quotes & Memorable Moments
-
On Oncologist Burnout:
"They have limited bandwidth because they’re exhausted. Two, there are so many different things going on in terms of care and treatment and ways to handle diseases that they just can't keep up and they're exhausted and it's almost impossible."
— Scott Becker (00:48) -
On AI’s Real-World Value:
"That had moved beyond just sort of this guy Eeroka Afkowski’s company to a real, real thing."
— Scott Becker (02:46) -
On The Need for AI Tools:
“It’s no question why these types of things, these types of AI, clinical helpful tools are so, so important because quite frankly, the doctors are overwhelmed.”
— Scott Becker (03:20)
Timestamps: Important Segments
- 00:21 – Introduction to Tempus AI and Eric Lefkowski
- 00:48 – Oncologist exhaustion and the rising complexity of oncology care
- 01:33 – Why patients flock to top cancer centers
- 01:52 – Tempus AI’s niche and growing importance
- 02:18 – Tempus AI’s market performance and credibility
- 02:42 – Personal anecdote underscoring Tempus’s legitimacy
- 03:20 – Final emphasis on systemic need for AI augmentation
This episode, delivered in Scott Becker’s plainspoken and urgent tone, serves as a concise exploration of why advanced analytics and AI are quickly becoming non-negotiable in modern oncology—and the ways these tools are already shaping clinical practice, patient care, and healthcare workflows.
